The struggles at Heartware International continue as the company saw continued year-over-year losses in the second quarter of 2016. Medtronic to buy Heartware for $1.1B Medtronic announced Monday that ...

Here at The Motley Fool, I've long cautioned investors to keep a close eye on inventory levels. It's a part of my standard diligence when searching for the market's best stocks. I think a quarterly ...

Forbes contributors publish independent expert analyses and insights. We write about stock options with a focus on yield. Selling a put does not give an investor access to HTWR's upside potential the ...

Five years after Medtronic's billion-dollar purchase of HeartWare International, the company discontinued the device at the center of acquisition — a miniaturized, implantable heart pump — with no ...

*Refers to the latest 2 years of stltoday.com stories. Cancel anytime. Medtronic Plc said it would buy HeartWare International Inc for about $1.1 billion, bulking up its portfolio of devices for ...

Medtronic has agreed to pay a $54.5 million class-action settlement to investors to resolve allegations that a heart-pump company it acquired in 2016, HeartWare, repeatedly misled investors about the ...

The FDA said today that it had granted approval to the HeartWare Ventricular Assist System for use in heart failure patients waiting for a transplant. Approval of the device had been expected after ...

The US Food and Drug Administration (FDA) is notifying physicians of a Class I recall of unimplanted HeartWare ventricular assist device (VAD) implant kits, initiated voluntarily by the company in ...

Heartware International (NAS: HTWR) is expected to report Q4 earnings around Feb. 15. Here's what Wall Street wants to see: Comparing the upcoming quarter to the prior-year quarter, average analyst ...

Shares of Heartware International Inc. were indicated sharply higher in premarket trade Monday, after the developer of miniaturized circulatory support technologies agreed to be acquired by Medtronic ...